Literature DB >> 11197573

Pulmonary edema associated with rosiglitazone and troglitazone.

M L Thomas, S J Lloyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11197573     DOI: 10.1345/aph.10132

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  11 in total

1.  Control of lower extremity edema in patients with diabetes: Double blind randomized controlled trial assessing the efficacy of mild compression diabetic socks.

Authors:  Stephanie C Wu; Ryan T Crews; Melissa Skratsky; Julia Overstreet; Sai V Yalla; Michelle Winder; Jacquelyn Ortiz; Charles A Andersen
Journal:  Diabetes Res Clin Pract       Date:  2017-02-27       Impact factor: 5.602

2.  Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability.

Authors:  I Idris; S Gray; R Donnelly
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

3.  Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

Authors:  Hui Zhang; Aihua Zhang; Donald E Kohan; Raoul D Nelson; Frank J Gonzalez; Tianxin Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

4.  Bioimpedance spectroscopy for the estimation of body fluid volumes in mice.

Authors:  M E Chapman; L Hu; C F Plato; D E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

Review 5.  Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Antona J Wagstaff; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.

Authors:  Stephane Renauld; Karine Tremblay; Siham Ait-Benichou; Maxime Simoneau-Roy; Hugo Garneau; Olivier Staub; Ahmed Chraïbi
Journal:  J Membr Biol       Date:  2010-08-26       Impact factor: 1.843

8.  Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.

Authors:  Ji-Young Park; Kyoung-Ah Kim; Jae-Gook Shin; Ki Young Lee
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 9.  Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.

Authors:  Tianxin Yang; Sunhapas Soodvilai
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.